Complement Factor H Polymorphism and Age-Related Macular Degeneration
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association ( P = 4.95 × 10 -10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 → histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [108]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [35]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [4]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.785 · Cited by 398
Keenan, T. D., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 377
Research works printed but not linked: 1
- M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol.27, 2351 (2000).
Cited by
Items 201–300 of 1,021
Ding, J.-D., Johnson, L. V., Herrmann, R., Farsiu, S., Smith, S. G., Groelle, M., Mace, B. E., Sullivan, P., Jamison, J. A., Kelly, U., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100901108 · Cited by 188
“Bruban J, et al. (2009) Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells.”
BackgroundInfluentialImmune mechanisms in inflammatory and degenerative eye disease
Perez, V. L., & Caspi, R. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.003 · Cited by 188
Schaumberg, D. A. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.1.55 · Cited by 192
The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases
DeMaio, A., Mehrotra, S., Sambamurti, K., & Husain, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02605-9 · Cited by 174
“One component of complement called complement factor H (CFH) is an important inhibitor of the alternative pathway of complement, and CFH polymorphisms have been linked to an increased risk of AMD development [88, 183].”
BackgroundVEGF polymorphisms are associated with neovascular age-related macular degeneration
Churchill, A. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl238 · Cited by 189
Zareparsi, S., Buraczynska, M., Branham, K. E. H., Shah, S., Eng, D., Li, M., Pawar, H., Yashar, B. M., Moroi, S. E., Lichter, P. R., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi154 · Cited by 190
Haines, J. L., Schnetz-Boutaud, N., Schmidt, S., Scott, W. K., Agarwal, A., Postel, E. A., Olson, L., Kenealy, S. J., Hauser, M., Gilbert, J. R., et al. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0116 · Cited by 189
Clark, S. J., Perveen, R., Hakobyan, S., Morgan, B. P., Sim, R. B., Bishop, P. N., & Day, A. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103986 · Cited by 188
Pickering, M. C., & Cook, H. T. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03574.x · Cited by 185
Cano, M., Thimmalappula, R., Fujihara, M., Nagai, N., Sporn, M., Wang, A. L., Neufeld, A. H., Biswal, S., & Handa, J. T. (2010) · Vision Research · doi:10.1016/j.visres.2009.08.018 · Cited by 184
Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury
Thurman, J. M., Renner, B., Kunchithapautham, K., Ferreira, V. P., Pangburn, M. K., Ablonczy, Z., Tomlinson, S., Holers, V. M., & Rohrer, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808166200 · Cited by 185
Pachychoroid neovasculopathy and age-related macular degeneration
Miyake, M., Ooto, S., Yamashiro, K., Takahashi, A., Yoshikawa, M., Akagi-Kurashige, Y., Ueda-Arakawa, N., Oishi, A., Nakanishi, H., Tamura, H., et al. (2015) · Scientific Reports · doi:10.1038/srep16204 · Cited by 185
“In this study, pachychoroid neovasculopathy was diagnosed if all of the following criteria were met: (1) CNV in either eye; (2) subfoveal choroidal thickness ≥200 μ m in both eyes; (3) no drusen or only non-extensive (total area, ≤ 125 μ m circle) hard drusen (≤ 63 μ m) in both eyes (AREDS category 1, no AMD); (4) CSC…”
BackgroundInfluentialSepp, T., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Moore, A. T., Bird, A. C., & Yates, J. R. W. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1143 · Cited by 186
IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease
Tremelling, M., Cummings, F., Fisher, S. A., Mansfield, J., Gwilliam, R., Keniry, A., Nimmo, E. R., Drummond, H., Onnie, C. M., Prescott, N. J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.051 · Cited by 182
Clark, S. J., Higman, V. A., Mulloy, B., Perkins, S. J., Lea, S. M., Sim, R. B., & Day, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605083200 · Cited by 185
On phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
“AMD is associated with the single nucleotide polymorphism (SNP) rs1061170 of the CFH gene (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005) that leads to the substitution of histidine 402 for tyrosine (Y402H) in the SCR7 domain.”
BackgroundStructural basis for complement factor H linked age-related macular degeneration
Prosser, B. E., Johnson, S., Roversi, P., Herbert, A. P., Blaum, B. S., Tyrrell, J., Jowitt, T. A., Clark, S. J., Tarelli, E., Uhrín, D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071069 · Cited by 184
Chen, M., Forrester, J. V., & Xu, H. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.11.015 · Cited by 175
“More recently a gene polymorphism in the major complement regulatory component, factor H (CFH), has been shown to be a high risk factor for AMD (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005; Hageman et al., 2005).”
BackgroundOxidation and age-related macular degeneration: insights from molecular biology
Khandhadia, S., & Lotery, A. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941000164x · Cited by 181
Nature and nurture- genes and environment- predict onset and progression of macular degeneration
Sobrin, L., & Seddon, J. M. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.12.004 · Cited by 178
“Starting with the common coding variant Y402H in the CFH gene on chromosome 1 found by GWAS, (Klein R.J. et al., 2005) odds ratios associated with the homozygous risk genotype varied between 2.45 and 3.33 (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein R.J. et al., 2005).”
InfluentialAudo, I., Bujakowska, K. M., Léveillard, T., Mohand-Saïd, S., Lancelot, M.-E., Germain, A., Antonio, A., Michiels, C., Saraiva, J.-P., Letexier, M., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-8 · Cited by 175
Age‐related macular degeneration—clinical review and genetics update
Ratnapriya, R., & Chew, E. Y. (2013) · Clinical Genetics · doi:10.1111/cge.12206 · Cited by 176
Kohno, H., Chen, Y., Kevany, B. M., Pearlman, E., Miyagi, M., Maeda, T., Palczewski, K., & Maeda, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448712 · Cited by 176
“4 The abbreviations used are: AMD, age-related macular degeneration; atRAL, all-trans-retinal; ABCA4, ATP-binding cassette transporter 4; AF, autofluorescent; BRB, blood-retinal barrier; CFH, complement factor H; GFAP, glial fibrillary acidic protein; Mertk, c-mer proto-oncogene tyrosine kinase; POS, photoreceptor out…”
BackgroundInfluentialSchmitz-Valckenberg, S., Bindewald-Wittich, A., Dolar-Szczasny, J., Dreyhaupt, J., Wolf, S., Scholl, H. P. N., & Holz, F. G. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0892 · Cited by 181
Begum, R., Powner, M. B., Hudson, N., Hogg, C., & Jeffery, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057828 · Cited by 179
Zhan, X., Larson, D. E., Wang, C., Koboldt, D. C., Sergeev, Y. V., Fulton, R. S., Fulton, L. L., Fronick, C. C., Branham, K. E., Bragg-Gresham, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2758 · Cited by 179
Self-citationReticular Drusen Associated with Geographic Atrophy in Age-Related Macular Degeneration
Schmitz-Valckenberg, S., Alten, F., Steinberg, J. S., Jaffe, G. J., Fleckenstein, M., Mukesh, B. N., Hohman, T. C., & Holz, F. G. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-7235 · Cited by 178
Therapeutic targets in age-related macular disease
Bird, A. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42437 · Cited by 175
Langer, H. F., Chung, K.-J., Orlova, V. V., Choi, E. Y., Kaul, S., Kruhlak, M. J., Alatsatianos, M., DeAngelis, R. A., Roche, P. A., Magotti, P., et al. (2010) · Blood · doi:10.1182/blood-2010-01-261503 · Cited by 176
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
Caprara, C., & Grimm, C. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.003 · Cited by 176
Seddon, J. M., George, S., Rosner, B., & Klein, M. L. (2006) · Human Heredity · doi:10.1159/000094141 · Cited by 176
Jirarattanasopa, P., Ooto, S., Nakata, I., Tsujikawa, A., Yamashiro, K., Oishi, A., & Yoshimura, N. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9619 · Cited by 175
Abokyi, S., To, C.-H., Lam, T. T., & Tse, D. Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7901270 · Cited by 167
Age-related macular degeneration and the complement system
Khandhadia, S., Cipriani, V., Yates, J. R. W., & Lotery, A. J. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.07.019 · Cited by 167
The innate immune response to products of phospholipid peroxidation
Weismann, D., & Binder, C. J. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.018 · Cited by 170
Swaroop, A., Branham, K. E., Chen, W., & Abecasis, G. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm212 · Cited by 173
Ocular blood flow in diabetes and age-related macular degeneration
Pemp, B., & Schmetterer, L. (2008) · Canadian Journal of Ophthalmology · doi:10.1139/i08-049 · Cited by 167
Klein, M. L., Francis, P. J., Rosner, B., Reynolds, R., Hamon, S. C., Schultz, D. W., Ott, J., & Seddon, J. M. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.01.036 · Cited by 172
Neuroprotective Effects of Lutein in the Retina
Ozawa, Y., Sasaki, M., Takahashi, N., Kamoshita, M., Miyake, S., & Tsubota, K. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798919101 · Cited by 166
The genetics of asthma and the promise of genomics-guided drug target discovery
El-Husseini, Z. W., Gosens, R., Dekker, F., & Koppelman, G. H. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30363-5 · Cited by 161
Ennis, S., Jomary, C., Mullins, R., Cree, A., Chen, X., MacLeod, A., Jones, S., Collins, A., Stone, E., & Lotery, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61348-3 · Cited by 171
Genetic susceptibility to myocardial infarction and coronary artery disease
Topol, E. J., Smith, J., Plow, E. F., & Wang, Q. K. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl183 · Cited by 173
Inflammation, the complement system and the diseases of aging
McGeer, E. G., Klegeris, A., & McGeer, P. L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.008 · Cited by 170
Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling
Mukherjee, P. K., Marcheselli, V. L., Barreiro, S., Hu, J., Bok, D., & Bazan, N. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705949104 · Cited by 170
Cone- and Rod-Mediated Dark Adaptation Impairment in Age-Related Maculopathy
Owsley, C., McGwin, G., Jackson, G. R., Kallies, K., & Clark, M. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.12.023 · Cited by 168
Genetics of age-related macular degeneration (AMD)
DeAngelis, M. M., Owen, L. A., Morrison, M. A., Morgan, D. J., Li, M., Shakoor, A., Vitale, A., Iyengar, S., Stambolian, D., Kim, I. K., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx228 · Cited by 164
Self-citationJones, B. W., Kondo, M., Terasaki, H., Lin, Y., McCall, M., & Marc, R. E. (2012) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-012-0147-2 · Cited by 162
Souied, E. H., Leveziel, N., Richard, F., Dragon‐Durey, M., COSCAS, G. J., Soubrane, G., Benlian, P., & Frémeaux‐Bacchi, V. (2005) · Molecular vision · Cited by 189
Immunopathological aspects of age-related macular degeneration
Patel, M., & Chan, C.-C. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0112-9 · Cited by 164
The Genetics of Autism: Key Issues, Recent Findings, and Clinical Implications
El-Fishawy, P., & State, M. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.002 · Cited by 166
“[20] A similar situation has been identified with respect to macular degeneration.[21,22]”
BackgroundDietary hyperglycemia, glycemic index and metabolic retinal diseases
Chiu, C.-J., & Taylor, A. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.09.001 · Cited by 156
“proteins are coated with complement and can bind complement factor H (CFH), which has been identified as a major inflammatory factor in AMD pathogenesis (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005).”
The complotype: dictating risk for inflammation and infection
Harris, C. L., Heurich, M., Cordoba, S. R. D., & Morgan, B. P. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.06.001 · Cited by 163
Kunchithapautham, K., Atkinson, C., & Rohrer, B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.564674 · Cited by 163
McFadyen, J. D., Kiefer, J., Braig, D., Loseff-Silver, J., Potempa, L. A., Eisenhardt, S. U., & Peter, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01351 · Cited by 152
“This SNP involving the CFH gene is considered one of the most significant genetic risk factors for AMD development (97).”
BackgroundLiu, B., Wei, L., Meyerle, C., Tuo, J., Sen, H. N., Li, Z., Chakrabarty, S., Agron, E., Chan, C.-C., Klein, M. L., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-111 · Cited by 164
“Several research teams have reported that a common SNP of CFH, Tyr(402)His, has a particularly strong association with AMD [4,6,8].”
BackgroundCobra venom factor: Structure, function, and humanization for therapeutic complement depletion
Vogel, C.-W., & Fritzinger, D. C. (2010) · Toxicon · doi:10.1016/j.toxicon.2010.04.007 · Cited by 159
Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD)
Ramkumar, H. L., Zhang, J., & Chan, C.-C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.02.002 · Cited by 163
“…nucleotide polymorphisms in several genes, especially the Y402H variant of complement factor H (CFH) (Haines et al., 2005; Klein and Weleber, 1998; Klein et al., 2005; Edwards et al., 2005; Hageman et al., 2005), have been associated with AMD pathogenesis (Swaroop et al., 2007; Ding et al., 2009).”
BackgroundInfluentialComplement, Age-Related Macular Degeneration and a Vision of the Future
Gehrs, K. M. (2010) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.18 · Cited by 157
Complement factor H in AMD: Bridging genetic associations and pathobiology
Toomey, C. B., Johnson, L. V., & Bowes Rickman, C. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.09.001 · Cited by 161
“…in 2005 four separate studies identified single nucleotide polymorphism (SNP) variants within the complement factor H gene (CFH) on chromosome 1 that are associated with significantly increased risk for AMD (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundInfluentialGotoh, N., Yamada, R., Hiratani, H., Renault, V., Kuroiwa, S., Monet, M., Toyoda, S., Chida, S., Mandai, M., Otani, A., et al. (2006) · Human Genetics · doi:10.1007/s00439-006-0187-0 · Cited by 160
Factor H: A Complement Regulator in Health and Disease, and a Mediator of Cellular Interactions
Kopp, A., Hebecker, M., Svobodová, E., & Józsi, M. (2012) · Biomolecules · doi:10.3390/biom2010046 · Cited by 157
Jokiranta, T. S., Jaakola, V., Lehtinen, M. J., Pärepalo, M., Meri, S., & Goldman, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601052 · Cited by 173
“Recently, FH polymorphism was also found to be associated with age-related macular degen- eration, the most common cause of blindness in the elderly in the industrialized countries (e.g. Edwards et al, 2005).”
BackgroundMesenchymal Stem Cells Inhibit Complement Activation by Secreting Factor H
Tu, Z., Li, Q., Bu, H., & Lin, F. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0418 · Cited by 149
Soluble and Mature Amyloid Fibrils in Drusen Deposits
Isas, J. M., Luibl, V., Johnson, L. V., Kayed, R., Wetzel, R., Glabe, C. G., Langen, R., & Chen, J. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4207 · Cited by 153
Complement Factor H Polymorphism in Age-Related Macular Degeneration
Eagle, R. C. (2006) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(08)70394-0 · Cited by 159
Pickering, M. C., Warren, J. A., Rose, K. L., Carlucci, F., Wang, Y., Walport, M. J., Cook, H. T., & Botto, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601094103 · Cited by 159
Conley, Y. P., Thalamuthu, A., Jakobsdottir, J., Weeks, D. E., Mah, T., Ferrell, R. E., & Gorin, M. B. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi204 · Cited by 158
Conley, Y. P., Jakobsdottir, J., Mah, T., Weeks, D. E., Klein, R., Kuller, L., Ferrell, R. E., & Gorin, M. B. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl396 · Cited by 157
Radu, R. A., Hu, J., Yuan, Q., Welch, D. L., Makshanoff, J., Lloyd, M., McMullen, S., Travis, G. H., & Bok, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191866 · Cited by 157
Regulation of age-related macular degeneration-like pathology by complement factor H
Toomey, C. B., Kelly, U., Saban, D. R., & Bowes Rickman, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424391112 · Cited by 154
Nakanishi, H., Yamada, R., Gotoh, N., Hayashi, H., Yamashiro, K., Shimada, N., Ohno‐Matsui, K., Mochizuki, M., Saito, M., Iida, T., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000660 · Cited by 170
“Myopia is one of the most common ocular disorders worldwide, and is in much higher prevalence in Asians than in Caucasians.”
BackgroundA candidate gene approach to searching for low-penetrance breast and prostate cancer genes
The National Cancer Institute Breast and Prostate Cancer Cohort Consortium (2005) · Nature Reviews Cancer · doi:10.1038/nrc1754 · Cited by 159
An update on the genetics of age-related macular degeneration
Scholl, H. P. N., Fleckenstein, M., Issa, P. C., Keilhauer, C. N., Holz, F. G., & Weber, B. H. F. (2007) · PubMed · doi:10.5283/epub.35844 · Cited by 156
Major review: Molecular genetics of primary open-angle glaucoma
Liu, Y., & Allingham, R. R. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.05.002 · Cited by 168
Retinal synthesis and deposition of complement components induced by ocular hypertension
Kuehn, M. H., Kim, C. Y., Ostojić, J., Bellin, M., Alward, W. L. M., Stone, E. M., Sakaguchi, D. S., Grozdanić, S. D., & Kwon, Y. H. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.03.002 · Cited by 160
“Recently, genomic variations in the factor H gene, an inhibitor of the complement cascade, have been reported to be associated with the development of age-related macular degeneration (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundRohrer, B., Long, Q., Coughlin, B., Wilson, R. B., Huang, Y., Qiao, F., Tang, P. H., Kunchithapautham, K., Gilkeson, G. S., & Tomlinson, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2222 · Cited by 154
Dunaief, J. L. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0568 · Cited by 154
How does the macula protect itself from oxidative stress?
Handa, J. T. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.006 · Cited by 154
“The initial discovery made by several laboratories, was the association of a single nucleotide polymorphism (SNP) rs1061170 in complement factor H (CFH) with advanced AMD (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundSchmitz-Valckenberg, S., Steinberg, J. S., Fleckenstein, M., Visvalingam, S., Brinkmann, C. K., & Holz, F. G. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.10.044 · Cited by 165
Klein, R., Myers, C. E., Cruickshanks, K. J., Gangnon, R. E., Danforth, L. G., Sivakumaran, T. A., Iyengar, S. K., Tsai, M. Y., & Klein, B. E. K. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7671 · Cited by 150
Smailhodzic, D., Klaver, C. C. W., Klevering, B. J., Boon, C. J. F., Groenewoud, J. M. M., Kirchhof, B., Daha, M. R., den Hollander, A. I., & Hoyng, C. B. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.07.056 · Cited by 168
A2E Induces IL-1ß Production in Retinal Pigment Epithelial Cells via the NLRP3 Inflammasome
Anderson, O. A., Finkelstein, A., & Shima, D. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067263 · Cited by 149
Wu, Y., Yanase, E., Feng, X., Siegel, M. M., & Sparrow, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913112107 · Cited by 149
Ferreira, V. P., Herbert, A. P., Hocking, H. G., Barlow, P. N., & Pangburn, M. K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6308 · Cited by 131
Clark, S. J., Ridge, L. A., Herbert, A. P., Hakobyan, S., Mulloy, B., Lennon, R., Würzner, R., Morgan, B. P., Uhrín, D., Bishop, P. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201751 · Cited by 148
“These data correlate well with the evidence that the Y402H polymorphism (in CCP7) is associated with AMD (7-10,27), while mutations/polymorphisms in CCPs19-20 are associated with kidney diseases such as aHUS (5,6).”
InfluentialMcKay, G. J., Patterson, C. C., Chakravarthy, U., Dasari, S., Klaver, C. C., Vingerling, J. R., Ho, L., de Jong, P. T. V. M., Fletcher, A. E., Young, I. S., et al. (2011) · Human Mutation · doi:10.1002/humu.21577 · Cited by 151
“…identified risk and protective variants in several genes associated with the complement pathway and chronic inflammation such as factor H ( CFH ) [Edwards et al., 2005, Hageman et al., 2005; Haines et al., 2005; Hughes et al., 2006; Klein et al., 2005], component 2 ( CC2 )/factor B ( CFB )…”
BackgroundGenomewide Scan for Linkage Reveals Evidence of Several Susceptibility Loci for Alopecia Areata
Martínez-Mir, A., Zlotogorski, A., Gordon, D., Petukhova, L., Mo, J., Gilliam, T. C., Londoño, D., Haynes, C. A., Ott, J., Hordinsky, M., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511442 · Cited by 162
Regulatory role of HIF-1α in the pathogenesis of age-related macular degeneration (AMD)
Arjamaa, O., Nikinmaa, M., Salminen, A., & Kaarniranta, K. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.06.002 · Cited by 164
Complement analysis in the 21st century
Mollnes, T. E., Jokiranta, T. S., Truedsson, L., Nilsson, B., de Córdoba, S. R., & Kirschfink, M. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.150 · Cited by 165
Nordgaard, C. L., Berg, K. M., Kapphahn, R. J., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0976 · Cited by 149
Factor H-related proteins determine complement-activating surfaces
Józsi, M., Tortajada, A., Uzonyi, B., Goicoechea de Jorge, E., & Rodríguez de Córdoba, S. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.008 · Cited by 144
Complement in atherosclerosis: friend or foe?
Speidl, W. S., Kastl, S., Huber, K., & Wojta, J. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04172.x · Cited by 159
Hecker, L. A., Edwards, A. O., Ryu, E., Tosakulwong, N., Baratz, K. H., Brown, W. L., Issa, P. C., Scholl, H. P., Pollok-Kopp, B., Schmid-Kubista, K. E., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp472 · Cited by 147
Self-citationBharti, K., Miller, S. S., & Arnheiter, H. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00772.x · Cited by 146
“Among them are, for instance, the tyrosine402to-histidine substitution in complement factor H, and alleles of ApoE and complement factor C2 ⁄ BF (Baird et al., 2006; Edwards et al., 2005; Gold et al., 2006; Haines et al., 2005; Klein et al., 2005).”
BackgroundCardiovascular Disease and Hypertension Are Strong Risk Factors for Choroidal Neovascularization
Hogg, R. E., Woodside, J. V., Gilchrist, S. E. C. M., Graydon, R., Fletcher, A. E., Chan, W., Knox, A., Cartmill, B., & Chakravarthy, U. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.07.031 · Cited by 148
“Recently, polymorphisms in complement factor H and related genes were shown to confer a high risk for choroidal neovascularization, and this has resulted in a resurgence of interest in the hypothesis that inflammation and immune activation play a role in its development.(4,5) Although genetic factors account for some…”
BackgroundShaw, P. X., Zhang, L., Zhang, M., Du, H., Zhao, L., Lee, C., Grob, S., Lim, S. L., Hughes, G., Lee, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121309109 · Cited by 148
Realizing the Promise of Genomics in Biomedical Research
Guttmacher, A. E., & Collins, F. S. (2005) · JAMA · doi:10.1001/jama.294.11.1399 · Cited by 164
Extracellular Vesicles: Packages Sent With Complement
Karasu, E., Eisenhardt, S. U., Harant, J., & Huber-Lang, M. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00721 · Cited by 151
Reticular pseudodrusen: A critical phenotype in age-related macular degeneration
Wu, Z., Fletcher, E. L., Kumar, H., Greferath, U., & Guymer, R. H. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101017 · Cited by 154
Multiple, parallel cellular suicide mechanisms participate in photoreceptor cell death
Lohr, H. R., Kunchithapautham, K., Sharma, A. K., & Rohrer, B. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.01.014 · Cited by 158
Metadata
- Authors
- Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A.
- Affiliations
- Boston University (US)
- Corresponding author
- Edwards, Albert O.
- Venue
- Science
- Published
- 2005-04-15
- Volume
- 308
- Issue
- 5720
- Pages
- 421-424
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3145351529
- Cited by
- 2,449
- References
- 30
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 51 · 2023: 48 · 2022: 78 · 2021: 105 · 2020: 73 · 2019: 52 · 2018: 81 · 2017: 65 · 2016: 89 · 2015: 120 · 2014: 141 · 2013: 146 · 2012: 166
- FWCI
- 195.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY014467, R01EY014467)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, complement factor H, CFH Y402H polymorphism, single nucleotide polymorphisms, genetic association, disease risk
- MeSH terms
- Aged, Alleles, Chromosomes, Human, Pair 1, Complement Activation, Female, Gene Frequency, Multigene Family, Genotype, Haplotypes, Histidine, Homozygote, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Tyrosine, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Complement Factor H, Amino Acid Substitution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.